CN Patent

CN102188395B — 一种更稳定的美罗培南注射剂及其制备方法

Assigned to Shijiazhuang Pharmaceutical Group Ouyi Pharma Co Ltd · Expires 2012-12-05 · 13y expired

What this patent protects

本发明提供了一种更稳定的美罗培南注射剂及其制备方法，所述注射剂是脂质体冻干制剂由以下重量份的成分组成：美罗培南5-15份、磷脂80-160份、胆固醇50-110份、维生素E 0.15-0.50份、脱氧胆酸钠300-550份和糖30-100份。本发明提供的美罗培南脂质体冻干制剂具有以下优点：粒径小、包封率高、渗漏率低，稳定性好，解决了已上市的普通粉针剂室温下长时间输注所出现的不稳定问题，便于临床应用。

USPTO Abstract

本发明提供了一种更稳定的美罗培南注射剂及其制备方法，所述注射剂是脂质体冻干制剂由以下重量份的成分组成：美罗培南5-15份、磷脂80-160份、胆固醇50-110份、维生素E 0.15-0.50份、脱氧胆酸钠300-550份和糖30-100份。本发明提供的美罗培南脂质体冻干制剂具有以下优点：粒径小、包封率高、渗漏率低，稳定性好，解决了已上市的普通粉针剂室温下长时间输注所出现的不稳定问题，便于临床应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102188395B
Jurisdiction
CN
Classification
—
Expires
2012-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Pharmaceutical Group Ouyi Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.